Malignancies in patients with primary immunodeficiency due to mutations in NFKB1 or NFKB2

  • C. Klemann (Speaker)
  • T. Lorenzini (Speaker)
  • R. Kobbe (Speaker)
  • A. Hüfner (Speaker)
  • R. Sherka (Speaker)
  • T. W. Kuijpers (Speaker)
  • P. Tuijnenburg (Speaker)
  • H. Lango Allen (Speaker)
  • J. Thaventhiran (Speaker)
  • M. Cook (Speaker)
  • K. Warnatz (Speaker)
  • R. Ameratunga (Speaker)
  • K. Boztug (Speaker)
  • T. Hirschmugl (Speaker)
  • de Vries, E. (Speaker)
  • J. W. M. van der Meer (Speaker)
  • L. I. Gonzalez-Granado (Speaker)
  • L. M. Allende (Speaker)
  • T. Niehues (Speaker)
  • N. Brauer (Speaker)
  • W. Rae (Speaker)
  • F. Atschekzei (Speaker)
  • R. E. Schmidt (Speaker)
  • L. Alsina (Speaker)
  • M. Piquer-Gibert (Speaker)
  • A. Deyà-Martínez (Speaker)
  • M. R. J. Seppänen (Speaker)
  • M. Fliegauf (Speaker)
  • B. Grimbacher (Speaker)

Activity: Talk or presentation typesOral presentationProfessional

Period18 Sep 201921 Sep 2019
Event titleESID 2019 Focused Meeting : Immunodeficiencies with increased risk of cancer
Event typeConference
LocationBrussels, Belgium
Degree of RecognitionInternational